50268-032-12 : NDC 2026 Code

50268-032-12 : Abiraterone Acetate ( Abiraterone Acetate )

Additionally :

You can get information about “50268-032-12” NDC code in 50268-032-12 in HTML format

HTML | 50268-032-12 in TXT (Plain Text) format

TXT | 50268-032-12 in PDF (Portable Document Format)

PDF | 50268-032-12 in XML format

XML formats.

NDC Code : 50268-032-12 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "50268-032-12",
    "PackageDescription": "20 BLISTER PACK in 1 BOX (50268-032-12)  / 1 TABLET in 1 BLISTER PACK (50268-032-11) ",
    "NDC11Code": "50268-0032-12",
    "ProductNDC": "50268-032",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Abiraterone Acetate",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Abiraterone Acetate",
    "DosageFormName": "TABLET",
    "RouteName": "ORAL",
    "StartMarketingDate": "20260504",
    "EndMarketingDate": null,
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA208416",
    "LabelerName": "AvPAK",
    "SubstanceName": "ABIRATERONE ACETATE",
    "StrengthNumber": "250",
    "StrengthUnit": "mg/1",
    "Pharm_Classes": "Cytochrome P450 17A1 Inhibitor [EPC], Cytochrome P450 17A1 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2026-05-06",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20271231",
    "StartMarketingDatePackage": "20260504",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}